Pharma Regulation

Pharma Regulation & Policy

In this section you will find information products, including market research, covering regulatory issues concerning the global biotechnology & pharmaceutical industries, including Good Laboratory & Clinical Practice (GLP & GCP), pricing & reimbursement and drug approval in Europe, the US and Asia.

 


Stay up-to-date with new products added to this category »
Title Publication Date Price
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: UK December 2011 £420
Drug Recalls and Warning Letters
Increasing Numbers Caused by Manufacturing Errors and Regulatory Non-Compliance Issues
November 2011 £2215
Pharmacovigilance and Other Pharma Regulatory Developments
2011 - 2021
August 2011 £1499
Pharmacovigilance and Related Developments
2011-2021
August 2011 £1499
MSL-KOL Engagement
Ensuring Compliance
June 2011 £335
India Pharmaceutical Regulatory Report 2011 (Report Only) April 2011 £475
Chinese Pharmaceutical Regulatory Report 2011 (with Appendix) April 2011 £1010
Martindale: The Complete Drug Reference
37th edition
April 2011 £399.99
Impact of Healthcare Reforms on the Medical Technology Industry March 2011 £4110
Latest Chinese Regulations for Imported Drug Registration
China Pharmaceutical Guidebook
February 2011 £945
Reforms to the Pharmaceutical Benefits Scheme in Australia February 2011 £315
A Guidebook of Registration Application for Imported Chemical Drugs China Pharmaceutical Guidebook Series (2) (3rd edition)
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration
February 2011 £475
A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (3rd edition)
Latest Chinese Regulations for Imported Drug Registration
February 2011 £475
The Dietary Supplements Regulatory and Market Outlook February 2011 £3030
A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines China Pharmaceutical Guidebook Series (3) (3rd edition)
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration
February 2011 £475
A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (3rd edition)
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration
February 2011 £475
Biosimilars Regulatory Update
an evolving landscape
February 2011 £295
US Regulatory Trends During 2010
A Rapidly Changing Environment
January 2011 £305
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market August 2010 £2940
Healthcare Reform
2010 Medical Device Industry Perceptions Survey
August 2010 £6325
Pricing & Reimbursement in Emerging Markets
Analysis of pricing mechanisms and the influence of public and private sector health insurance provision
August 2010 £2425
Pay-for-Delay
An Unsettled Future Lies Ahead
July 2010 £295
The Impact of Healthcare Reform on Revenue Management
Unsettled and Uncertain
June 2010 £950
Pricing and Reimbursement Strategies for Diagnostics
Overcoming reimbursement issues and navigating the regulatory environment
June 2010 £2425
US Healthcare Reform
Impact and Implications for the Pharmaceutical and Biotech Industries
May 2010 £220
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
2nd edition
May 2010 £1705
Healthcare Reform
Impact on Medical Device Industry
April 2010 £315
Japan Compliance Environmental, Health, and Safety Management Trends 2009 February 2010 £3160
Business Strategy: Healthcare Reform
Impact on Healthcare Payer Business and Technology Priorities in the 2010 Decade
January 2010 £2845
Pharmas Seek FDA Guidance on Social Media November 2009 £950

Receive latest news

Keep me up-to-date with exciting new reports and offers
(maximum 1 email a week)


Captcha

NOTE: We will never sell, rent or loan your e-mail address to any other organisation. Remember you can unsubscribe at any time.

Follow us on twitter